AEHR Test Systems 2024 Annual Report: A Year of Growth and Innovation
Aehr Test Systems, a frontrunner in the semiconductor testing solutions market, has released its annual report for the fiscal year 2024, showcasing a year marked by significant revenue growth and strategic product innovations. As the demand for semiconductors continues to surge across various sectors, AEHR is well-positioned to capitalize on these trends.
1. Overview of Financial Performance
In fiscal year 2024, AEHR Test Systems reported a revenue increase of $1.3 million, bringing the total revenue to $66.21 million, up from $64.96 million in 2023. This growth is primarily attributed to a significant rise in sales of contactors, which saw an impressive growth of 71.72% year-over-year.
Revenue Breakdown
The company's revenue is derived from several key geographic regions and product segments. The following pie charts illustrate the distribution of revenue by geography and product/service type for the year 2024.
Product Line Highlights
AEHR's innovative product lineup has been a cornerstone of its growth strategy. The introduction of the FOX-P family of test and burn-in systems, as well as the FOX WaferPak and DiePak systems, has allowed AEHR to meet the evolving needs of the semiconductor industry.
Despite a decline in revenue from systems, which dropped by 37.78%, the overall performance was buoyed by the robust growth in contactors and steady service revenue.
2. Operating Results and Margins
Gross margin for AEHR decreased slightly from 50.4% in 2023 to 49.1% in 2024. This decline was primarily due to increased inventory reserves and higher costs associated with design changes. The company remains focused on improving manufacturing efficiencies and reducing direct material costs to enhance profitability.
Expense Management
Research and development (R&D) expenses increased by $1.6 million to $8.71 million, reflecting the company's commitment to innovation through higher employment-related costs and engineering services. Selling, general, and administrative expenses also rose by $1.5 million, reaching $13.74 million, driven by increased legal and audit service fees.
3. Geographic Revenue Insights
The geographic revenue distribution reflects a strategic shift towards international markets. Revenues from Asia grew by 4.44% to $58.07 million, while Europe saw an astonishing increase from just $63,000 in 2023 to $4.61 million in 2024, marking a remarkable growth of 7,210%. However, revenue from the United States declined by 61.98%, highlighting the competitive pressures and challenges faced in the domestic market.
4. Balance Sheet Strength
AEHR's balance sheet shows robust growth, with total assets rising to $127.9 million, up from $98.14 million in 2023. The company reported cash and cash equivalents of $49.15 million, a significant increase from $30.05 million the previous year, providing a strong liquidity position to support ongoing operations and future investments.
| Aug 2023 | Jul 2024 | |
|---|---|---|
Total Assets | 98.14M | 127.9M |
Total Current Assets | 89.03M | 97.84M |
Cash and Equivalents | 30.05M | 49.15M |
Short-term Investments | 17.85M | 0 |
Net Inventories | 23.90M | 37.47M |
Accounts Receivable | 16.59M | 0 |
Prepaid Expenses | 621K | 1.42M |
Other Current Assets | 0 | 9.79M |
Total Non-current Assets | 9.11M | 30.06M |
Non-current Deferred Tax Assets | 0 | 20.77M |
Net PP&E | 2.75M | 3.25M |
Lease Assets | 6.12M | 5.73M |
Other Non-current Assets | 231K | 304K |
Total Liabilities and Equity | 98.14M | 127.9M |
Total Liabilities | 22.54M | 16.31M |
Total Current Liabilities | 16.30M | 10.50M |
Accounts Payable and Accrued Liabilities | 13.34M | 8.69M |
Current Debt | 137K | 465K |
Current Deferred Revenue | 0 | 1.34M |
Other Current Liabilities | 2.82M | 0 |
Total Non-current Liabilities | 6.23M | 5.81M |
Non-current Deferred Revenue | 31K | 41K |
Other Non-current Liabilities | 6.20M | 5.77M |
Total Equity and Non-controlling Interests | 75.6M | 111.5M |
Total Equity | 75.6M | 111.5M |
5. Cash Flow Analysis
The cash flow statement reveals a net change in cash of $19.10 million for 2024, a substantial turnaround from a negative cash flow of $1.36 million in 2023. This improvement is primarily due to increased operating cash flow, indicating that AEHR is generating sufficient funds to support its growth initiatives.
| Aug 2023 | Jul 2024 | |
|---|---|---|
Net Change in Cash | -1.36M | 19.10M |
Effect of Exchange Rate Changes | -37K | -41K |
Net Cash from Operating Activities | 10.01M | 1.75M |
Operating Profit | 14.55M | 33.15M |
Adjustment to Operating Profit | -4.54M | -31.4M |
Net Cash from Investing Activities | -18.65M | 17.25M |
Investments | 17.29M | -18M |
Productive Assets | 1.36M | 749K |
Net Cash from Financing Activities | 7.32M | 139K |
Equity Issuance/Repurchase | 6.82M | 1.73M |
Other Financing Activities | 502K | -1.59M |
6. Legal Proceedings and Market Outlook
In a positive note, AEHR confirmed that there are no ongoing or pending legal proceedings against the company, which bodes well for its reputation and operational stability.
The outlook for AEHR remains positive as it continues to navigate the semiconductor industry's complexities. With its innovative solutions and commitment to quality, AEHR is poised to capture further market share in the growing sectors of electric vehicles, renewable energy, and telecommunications.
7. Conclusion
AEHR Test Systems has demonstrated resilience and growth in an increasingly competitive environment. With a solid financial foundation, strategic investments in R&D, and a commitment to innovation, AEHR is well-equipped to meet the demands of the semiconductor market in the coming years. The focus on international expansion and product development positions the company for continued success in 2025 and beyond.
| Aug 2023 | Jul 2024 | |
|---|---|---|
Net Income | 14.55M | 33.15M |
Profit | 14.55M | 33.15M |
Net Income Continuing | 14.55M | 33.15M |
Income Tax Expense | 60K | -20.69M |
Pretax Income | 14.61M | 12.45M |
Non-operating Income | 1.24M | 2.38M |
Operating Income | 13.37M | 10.07M |
Revenue | 64.96M | 66.21M |
Costs and Expenses | 51.58M | 56.14M |
Cost of Revenue | 32.21M | 33.67M |
Operating Expenses | 19.37M | 22.46M |
Research & Development | 7.13M | 8.71M |
Selling, General & Administrative | 12.23M | 13.74M |